Jasper Therapeutics, Inc.
JSPR· Nasdaq
Jasper Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -4.82%
- Market cap
- $18.98M
- 33.27M shares
- Filings
- 472
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $246,000 | reported | |
| FY 2022 | 2022-12-31 | $115,000 | reported | |
| FY 2021 | 2021-12-31 | $80,000 | reported | |
| FY 2020 | 2020-12-31 | $111,000 | reported |
Jasper Therapeutics, Inc. · CIK 1788028 · Engraved from SEC EDGAR
